Furthermore, 2′-OMe-modified siBRAF-Mut1_2′-OMe and siBRAF-Mut2_2′-OMe exhibited strong suppression activities on Mut BRAF mRNA in both in vitro (Supplementary Figure S4) and in vivo xenograft tumor models (Figure 5). The gene discussed is BRAF; the disease is neoplasm.